It contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial growth and keeps your reconstituted solution safe for the 3 to 4 weeks you will be drawing from the vial
Tirzepatide, a dual-agonist peptide, has shown significant results with a 22.5% weight loss over 72 weeks at a 15 mg dose (Jastreboff et al., NEJM), making it one of the most effective therapies for obesity
Anti-Inflammatory Benefits Chronic low-grade inflammation often accompanies obesity, and while weight loss generally improves inflammatory markers, the process itself can temporarily increase certain inflammatory responses
Potential Benefits Soft-tissue repair (preclinical): Animal data on BPC-157 and TB-500 describes faster tendon, ligament and muscle repair via angiogenesis and cell migration
If you have recent labs from your primary care provider (within the past 36 months), you may bring those in for review